CollaneX Therapeutics: working on a breakthrough in the fight against fibrosis
Fibrosis is the excessive formation of connective tissue in an organ or tissue; it is known from scars, but it can also occur in the liver as a result of obesity. An unhealthy lifestyle causes liver fibrosis to increase to such an extent that the disease almost begins to take on epidemic proportions, and no medicine is yet available. TNO has built up unique knowledge over the past decade that it wants to co-develop further with market parties into an effective medicine. This is currently being done by the newly founded CollaneX Therapeutics, a spin-off company of TNO. This biotech company will develop medicines against fibrosis, initially during the first phase of development independently, later in collaboration with pharmaceutical companies.
Working on a breakthrough in the fight against fibrosis
Fibrosis is the excessive formation of connective tissue in an organ or tissue; it is known from scars, but it can also occur in the liver as a result of obesity. An unhealthy lifestyle causes liver fibrosis to increase to such an extent that the disease almost begins to take on epidemic proportions, and no medicine is yet available. TNO has built up unique knowledge over the past decade that it wants to co-develop further with market parties into an effective medicine.
This is currently being done by the newly founded CollaneX Therapeutics, a spin-off company of TNO. This biotech company will develop medicines against fibrosis, initially during the first phase of development independently, later in collaboration with pharmaceutical companies.
Number of patients growing
Efforts to develop anti-fibrosis medicines are happening worldwide. Fibrosis can occur in many organs, such as the heart, lungs, liver and kidneys, and the number of patients with liver fibrosis is rising sharply. In the US alone 130 million people are affected by obesity, which in many cases leads to liver disorders and consequently an increase in the number of liver transplants as a result of fibrosis.
Why from TNO?
As a TNO spin-off, CollaneX has unique knowledge of both the disease and the pharmaceutical market. The scientists forming the company have developed numerous models that provide insight into the mechanisms of the disease as well as identified a unique target that helps to develop a medicine with potentially few side effects. The unique combination of knowledge of mechanisms, models and the market has convinced CollaneX that it can make a breakthrough in the fight against fibrosis.
Contact us
-
Susanna Rademaekers
Functie:Tech Transfer Support-
Standplaats:Den Haag - New Babylon
-
Telefoon:+31 6 15 93 16 57
-
Email:Email Susanna
-
LinkedIn:Susanna on LinkedIn
-
Get inspired
Quantum internet enabled by space
Building on our combined know-how in quantum, free space optics and classical networks, TNO is working hard to enable quantum internet from space. In this webinar, Charlotte Postma and Gustavo Castro do Amaral will get you up to speed on the achievements so far, and the steps ahead.
Time setters: The future of military land operations with MICE and HUVIX simulators
At TNO, we make a mark on our time. In this series, you’ll meet the TNO employees behind the innovations – the time setters. What do they do exactly and what impact does their work have on society? In this episode, we talk to time setter Maarten Michel, an interaction design researcher at Human Machine Teaming in Soesterberg, about how military personnel can perform optimally on land using the HUVIX and the MICE.
Supporting municipalities to achieve heat transition
Local governments, especially municipalities, play a crucial role in the heat transition. Over 90 per cent of homes in the Netherlands are currently heated using fossil fuel, mainly natural gas. Find out how TNO supports municipalities with knowledge, experience and tools for sustainable heat sources like geothermal.
TNO launches digital health spin-off AIKON Health for wearable monitoring
TNO launches digital health spin-off AIKON Health for wearable monitoring.
Wind turbine inspections with autonomous drones and digital twin modelling
Wind turbine blade inspections can be faster, cheaper and safer. TNO and SpectX are combining their expertise areas on a new one-year project known as the IBIS project (Increased Blade Inspection Safety).
